Evaluation of microsatellite analysis in urine sediment for diagnosis of bladder cancer

Cancer Research

Volumn 60, Issue 16, 2000, Pages 4617-4622

  Schneider, Anne ^a   Borgnat, Stéphane ^b   Lang, Hervé ^b   Régine, Odile ^a   Lindner, Véronique ^c   Kassem, Maysoun ^c   Saussine, Christian ^b   Oudet, Pierre ^a   Jacqmin, Didier ^b   Gaub, Marie Pierre ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

^b Hospices civils de Strasbourg   (France)

^c UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSATELLITE DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CANCER GRADING; CANCER STAGING; DIAGNOSTIC ACCURACY; DNA SEQUENCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REPRODUCIBILITY; SEDIMENT; URINALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; CYSTOSCOPY; DNA, NEOPLASM; EVALUATION STUDIES; FEMALE; HUMANS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; NEOPLASM STAGING; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; URINARY BLADDER NEOPLASMS;

EID: 0034662623     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Epidemiology and etiology of bladder cancer
2. Cancer statistics 1994
3. Tobacco and bladder cancer in males: Increased risk for inhalers and smokers of black tobacco
4. Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer
5. Superficial bladder cancer: Survival and prognostic factors
6. Factors affecting recurrence and progression in superficial bladder tumors
7. Urinary cytology and bladder cancer. The cellular features of transitional cell neoplasms
8. Genetics of bladder cancer
9. Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization
10. 1 papillary bladder cancer detected by comparative genomic hybridization
11. Bladder cancer
12. Identification of p53 gene mutations in bladder cancers an urine samples
13. Analyses of p53 gene mutations in primary human bladder cancer
14. A molecular genetic model of human bladder cancer pathogenesis
15. Molecular alterations in bladder cancer
16. Accumulation of nuclear p53 and tumor progression in bladder cancer
17. Microsatellite alterations as clonal markers for the detection of human cancer
18. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis
19. Microsatellite instability in cancer of the proximal colon
20. Genetic mapping of a locus predisposing to human colorectal cancer
21. Microsatellite instability: Marker of a mutator phenotype in cancer
22. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability
23. Mismatch repair defects in human carcinogenesis
24. Microsatellite instability in colorectal cancer: Different mutator phenotypes and the principal involvement of HMLH1
25. Allelotype of colorectal cancer
26. Molecular genetic studies of the adenoma-carcinoma sequence
27. Molecular detection of primary bladder cancer by microsatellite analysis
28. Detection of bladder cancer recurrence by microsatellite analysis of urine
29. Sensitive detection of loss of heterozygosity in the Tp53 gene in pancreatic adenocarcinoma by fluorescence-based single-strand conformation polymorphism analysis using blunt-end DNA fragments
30. Assessment of microsatellite instability in urine in the detection of transitional-cell carcinoma of the bladder
31. Allelic loss on chromosome 9 in bladder cancer tissues and urine samples detected by blunt-end single-strand DNA conformation polymorphism
32. Diagnosis of renal cancer by molecular urinalysis
33. Initial evaluation of the bladder tumor antigen test in superficial bladder cancer
34. Comparison of screening methods in the detection of bladder cancer
35. Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancer
36. Multicenter trial of the quantitative BTA TRAK assay in the detection of bladder cancer
37. Comparison of the BTA stat test with voided urine cytology and bladder wash cytology in the diagnosis and monitoring of bladder cancer
38. The use of the BTA test in the detection of persistent or recurrent transitional-cell cancer of the bladder
39. Specific association of human telomerase activity with immortal cells and cancer
40. Mechanism of telomerase induction during T cell activation
41. Detailed deletion mapping of the long arm of chromosome 6 in adult T-cell leukemia
42. Frequent loss of heterozygosity on chromosomes 6q, 11, and 17 in human ovarian carcinomas
43. Common regions of deletion on chromosomes 5q, 6q, and 10q in renal cell carcinoma
44. Loss of genes on the short arm of chromosome 11 in bladder cancer
45. Expression of cyclin D1 and EMS1 in bladder tumors; relationship with chromosome 11q13 amplification
46. Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy
47. p53 mutations have no additional prognostic value over stage in bladder cancer
48. Molecular differential diagnosis of renal cell carcinomas by microsatellite analysis
49. Level of retinoblastoma protein expression correlates with p16 (MTS-1/INK4A/CDKN2) status in bladder cancer
50. Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: Implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer
51. Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in Von Hippel-Lindau disease patients
52. Recombinant adenovirus expressing Von Hippel-Lindau mediated cell cycle arrest is associated with the induction of cyclin-dependent kinase inhibitor p27Kip1
53. Loss of expression of transforming growth factor β type I and type II receptors correlates with tumor grade in human prostate cancer tissues
54. β-Catenin mutations in human prostate cancer
55. APC gene mutations in human prostate cancer
56. Changes in cadherin-catenin complexes in the progression of human bladder carcinoma
57. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues
58. A comparison between microsatellite and quantitative PCR analyses to detect frequent p16 copy number changes in primary bladder tumors
59. Use of a fluorescent-PCR reaction to detect genomic sequence copy number and transcriptional abundance